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Abstract
A simple, highly versatile and efficient synthesis of 1,2,4,5-tetrasubstituted imidazoles is achieved by four-component cyclo-
condensation of benzil, an aromatic aldehyde, aminoethylpiperazine and ammonium acetate using sulphated yttria as a catalyst in
ethanol. The synthesized compounds are characterized through IR, 1H and 13C NMR and HR-MS.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Taibah University. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Multicomponent reactions (MCRs) are atom econom-
ical and highly useful protocols in modern synthetic
organic chemistry. MCRs have great advantages, such as
short reaction time, low cost, low energy consumption,
high yield and easy purification processes without iso-
lation of intermediates [1]. Development of new MCRs
and improvement of known MCRs are popular areas of
research; one such reaction is imidazole synthesis using
the MCR strategy. Over recent years, imidazole scaffolds
have become a vital class of important heterocycles due∗ Corresponding author. Tel.: +91 9942547856;
fax: +91 4144 238080.
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(K. Krishnasamy).
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CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).to their abundance in natural products and their extensive
use in medicinal chemistry [2,3].
Imidazole scaffolds are particularly well known for
their anticancer [4], antifungal [5] and antibacterial
activities [6]. On the other hand, highly substituted imid-
azole derivatives possess good photophysical properties,
which result in their potential applications to mate-
rial chemistry, such as in organic electroluminescent
devices (OLED) [7]. In addition, imidazole derivatives
were utilized as ligands in metal-catalyzed reactions [8]
and as fluorescent probes [9]. Therefore, a variety of
synthetic routes has been devised for the synthesis of
imidazole analogues [10]. Imidazole ring systems show
a variety of pharmaceutical activities [11–13] and play
crucial roles in biochemical processes. It appears that the
highly substituted imidazoles could have novel therapeu-
tic activities [14], and they constitute an essential moiety
in a number of therapeutic agents, fungicides, herbicidesbehalf of Taibah University. This is an open access article under the
[15] and plant-growth regulators [16] in addition to being
known as inhibitors of p38 MAP kinase [14]. Further-
more, a recent report indicates that imidazoles are potent
inhibitors of protein–protein interactions [17].
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Numerous methods have been reported for the
ynthesis of 1,2,4,5-tetrasubstituted imidazoles by four-
omponent condensation of 1,2-diketone with an
ldehyde, a primary amine and ammonium acetate using
 heteropolyacid [18], BF3·SiO2 [19], silica gel/NaHSO4
20] or HClO4–SiO2 [21], ionic liquids [22], l-proline
23], ZrCl4 [24], InCl3·3H2O [25], K5CoW12O40·3H2O
26], molecular iodine [27], silica sulphuric acid [28],
iCl2·6H2O/Al2O3 [29], Yb(OTf)3 [30] selectfluor [31]
2SO4·SiO2 [32] and CAN [33]. In this study, we report
 facile, efficient and eco-friendly one-pot process for
he synthesis of 1,2,4,5-tetrasubstituted imidazoles 5a–o
hrough a four-component condensation reaction of ben-
il 1, substituted benzaldehyde 2, aminoethylpiperazine
 and ammonium acetate 4  in the presence of sulphated
ttria (SO42−/Y2O3), as an efficient and reusable cata-
yst in ethanol (Scheme 1). Currently, sulphated metal
nd mixed metal oxides have gained substantially more
ecognition for their significant catalytic activity than
etal and mixed metal oxides due to their higher num-
er of acid sites and larger surface area, which result in
nhanced catalytic activity [34].
.  Materials  and  methods
.1.  Chemicals  and  analysis
The chemicals were purchased from Merck, Fluka
nd Aldrich chemical companies. The melting points
ere recorded in an open capillary tube and were uncor-
1 13ected. The H and C NMR spectra of the synthesized
ompounds using CDCl3 as the solvent were recorded
n a Bruker Avance 400 or 500 MHz NMR spectrometer.
he 1H NMR and 13C NMR were referenced to TMSbstituted imidazole derivatives.
as an internal standard and the central line of CDCl3,
respectively. IR spectra were recorded using a JASCO
FT/IR-5300 spectrometer. High-resolution mass spec-
tra (HRMS) were recorded using electrospray ionization
on a Bruker Maxis instrument. Column chromatography
was performed using silica gel (100–120 mesh).
2.2.  General  procedure  for  preparation  of  1-(2-(2,4,
5-triphenyl-1H-imidazol-1-yl)ethyl)piperazine
(5a–o)
In a 50 mL round bottom flask, a mixture
of benzil (1 mmol), aromatic aldehyde (1 mmol),
aminoethylpiperazine (1 mmol), ammonium acetate
(2 mmol) and SO42−/Y2O3 (50 mg) [35] was stirred
and refluxed at 80 ◦C in ethanol (20 mL) for 10 h. The
progress of the reaction was monitored by TLC. After
completion of the reaction, the volume of the reac-
tion mixture was reduced, diluted with cold water and
extracted with ethyl acetate. The organic layer was
dried over anhydrous Na2SO4, and then the solvent was
removed under reduced pressure. The crude products
were subjected to purification by column chromatog-
raphy with silica gel (100–120 mesh size) using 20%
methanol in ethyl acetate as the eluent to yield 1,2,4,5-
tetrasustituted imidazoles (5a–5o).
2.2.1.  1-(2-(2,4,5-triphenyl-1H-imidazol-1-yl)
ethyl)piperazine  (5a)
Yield 1.784 g (93%). Yellow gummy solid (after col-
1umn chromatography). H NMR (CDCl3, 500 MHz)
δ 2.02 (s, 4H, (CH2)2NH), 2.23 (t, J  = 7.5 Hz, 2H,
CH2), 2.4 (s, 1H, NH), 2.64 (t, 4H, (CH2)2N), 4.03 (t,
J = 7.5 Hz, 2H, CH2), 7.12–7.73 (m, 15H); 13C NMR
h Univ500 R. Rajkumar et al. / Journal of Taiba
(CDCl3, 125 MHz) δ  41.88, 45.62, 54.07, 58.36, 126.31,
126.83, 128.08, 128.35, 128.67, 128.79, 128.96, 129.14,
129.29, 129.58, 131.09, 131.35, 131.37, 134.50, 137.75,
147.96; HRMS (ESI): calculated for C27H28N4 [M+H]+
409.2387; found 409.2391.
2.2.2.  1-(2-(4,5-diphenyl-2-(p-tolyl)-1H-imidazol-
1-yl)ethyl)piperazine  (5b)
Yield 1.845 g (93%). Yellow gummy solid (after col-
umn chromatography). 1H NMR (CDCl3, 500 MHz) δ
2.03 (s, 4H, (CH2)2NH), 2.24 (t, J  = 7.0 Hz, 3H, CH3),
2.42 (s, 2H, CH2), 2.66 (t, J = 4.5 Hz, 4H, (CH2)2N),
4.02 (t, J = 7.5 Hz, 2H, CH2), 7.12–7.48 (m, 14H);
13C NMR (CDCl3, 125 MHz) δ 21.40, 41.85, 45.69,
54.22, 58.34, 126.26, 126.84, 127.42, 127.81, 128.05,
128.34, 128.51, 128.73, 129.10, 129.14, 129.33, 129.44,
129.91, 131.01, 131.11, 131.43, 134.51, 137.62, 138.90,
148.06, HRMS (ESI): calculated for C28H30N4 [M+H]+
423.2544; found 423.2587.
2.2.3.  1-(2-(2-(4-bromophenyl)-4,5-diphenyl-1H-
imidazol-1-yl)ethyl)piperazine  (5c)
Yield 2.102 g (92%). Yellow gummy solid (after col-
umn chromatography). 1H NMR (CDCl3, 500 MHz) δ
2.08 (s, 4H, (CH2)2NH), 2.24 (t, J  = 7.0 Hz, 2H, CH2),
2.71 (t, J  = 5.0 Hz, 4H, (CH2)2N), 4.02 (t, J = 7.0 Hz,
2H, CH2), 7.14–7.63 (m, 14H); 13C NMR (CDCl3,
125 MHz) δ  42.11, 45.31, 53.66, 58.21, 123.30, 126.49,
126.83, 128.13, 128.35, 128.93, 129.20, 129.27, 129.93,
130.23, 130.67, 130.75, 130.97, 131.03, 131.11, 131.89,
131.97, 134.22, 138. 11, 146.80; HRMS (ESI): cal-
culated for C27H27BrN4 [M+H]+ 487.1492; found
487.1498.
2.2.4. 1-(2-(2-(4-chlorophenyl)-4,5-diphenyl-1H-
imidazol-1-yl)ethyl)piperazine  (5d)
Yield 1.891 g (91%). Yellow solid, mp 96–98 ◦C. 1H
NMR (CDCl3, 500 MHz) δ 2.05 (s, 4H, (CH2)2NH),
2.24 (t, J  = 7.5 Hz, 2H, CH2), 2.68 (t, J  = 4.5 Hz, 4H,
(CH2)2N), 4.02 (t, J = 7.5 Hz, 2H, CH2), 7.14–7.71 (m,
14H); 13C NMR (CDCl3, 125 MHz) δ  42.10, 45.73,
54.33, 58.38, 126.45, 126.57, 126.82, 128.12, 128.35,
128.91, 129.01, 129.18, 129.27, 129.80, 129.90, 130.43,
130.54, 130.98, 131.07, 131.16, 134.28, 135.03, 138.03,
146.77; HRMS (ESI): calculated for C27H27ClN4
[M+H]+ 443.1997; found 443.2001.
2.2.5.  1-(2-(2-(4-ﬂuorophenyl)-4,5-diphenyl-1H-
imidazol-1-yl)ethyl)piperazine  (5e)
Yield 1.822 g (91%). Yellow gummy solid (after col-
umn chromatography). 1H NMR (CDCl3, 500 MHz) δ
2.05 (s, 4H, (CH2)2NH), 2.24 (t, J  = 7.0 Hz, 2H, CH2),ersity for Science 9 (2015) 498–507
2.68 (t, J  = 4.5 Hz, 4H, (CH2)2N), 4.01 (t, J  = 7.5 Hz,
2H, CH2), 7.15–7.72 (m, 14H); 13C NMR (CDCl3,
125 MHz) δ  41.96, 45.61, 54.13, 58.33, 115.67, 115.84,
126.41, 126.80, 128.11, 128.14, 128.35, 128.86, 129.17,
129.26, 129.61, 130.99, 131.07, 131.20, 131.24, 131.27,
134.33, 137.81, 146.97; HRMS (ESI): calculated for
C27H27FN4 [M+H]+ 427.2293; found 427.2298.
2.2.6. 1-(2-(2-(4-nitrophenyl)-4,5-diphenyl-1H-
imidazol-1-yl)ethyl)piperazine  (5f)
Yield 1.853 g (87%). Yellow gummy solid (after col-
umn chromatography). 1H NMR (CDCl3, 400 MHz) δ
2.13 (s, 4H, (CH2)2NH), 2.25 (t, J = 7.2 Hz, 2H, CH2),
2.71 (s, 4H, (CH2)2N), 4.07 (t, J  = 6.8 Hz, 2H, CH2),
6.15–8.34 (m, 14H); 13C NMR (CDCl3, 100 MHz) δ
42.59, 44.07, 52.08, 57.85, 123.98, 126.84, 128.21,
129.24, 129.34, 129.63, 130.58, 130.91, 131.10, 133.80,
137.48, 139.06, 145.51, 147.64; HRMS (ESI): calculated
for C27H27N5O2 [M+H]+ 454.2238; found 454.2243.
2.2.7. 1-(2-(2-(4-methoxyphenyl)-4,5-diphenyl-1H-
imidazol-1-yl)ethyl)piperazine  (5g)
Yield 1.896 g (92%). Yellow solid, mp 99–101 ◦C.
1H NMR (CDCl3, 500 MHz) δ  2.09 (s, 4H, (CH2)2NH),
2.17 (d, J = 6.5 Hz, 2H, CH2), 2.70 (s, 4H, (CH2)2N),
3.80 (t, J = 4.5 Hz, 3H, OCH3), 3.95 (d, J  = 6.0 Hz,
2H, CH2), 6.53–7.57 (m, 14H); 13C NMR (CDCl3,
125 MHz) δ  41.88, 43.30, 50.72, 55.35, 57.46, 114.09,
114.17, 123.44, 126.37, 126.84, 126.88, 128.08, 128.78,
129.09, 129.18, 129.25, 130.50, 130.59, 130.89, 131.03,
131.21, 134.32, 137.57, 147.93, 160.18, 177.98; HRMS
(ESI): calculated for C28H30N4O [M+H]+ 439.2493;
found 439.2498.
2.2.8. 4-(4,5-diphenyl-1-(2-(piperazin-1-yl)ethyl)-
1H-imidazol-2-yl)-N,N-dimethylaniline  (5h)
Yield 1.931 g (91%). Red gummy solid (after col-
umn chromatography). 1H NMR (CDCl3, 400 MHz) δ
2.01 (d, J  = 2.8 Hz, 4H, (CH2)2NH), 2.23 (t, J  = 7.6 Hz,
2H, CH2), 2.40 (s, 1H, NH), 2.63 (t, J  = 4.4 Hz, 4H,
(CH2)2N), 2.97 (s, 6H, (NCH3)2), 3.99 (t, J = 7.6 Hz,
2H, CH2), 6.75–7.54 (m, 14H); 13C NMR (CDCl3,
100 MHz) δ  40.37, 41.80, 45.70, 54.20, 58.30, 112.05,
118.73, 126.08, 126.82, 128.00, 128.58, 129.04, 130.06,
131.13, 131.69, 134.75, 137.28, 148.63, 150.71; HRMS
(ESI): calculated for C29H33N5 [M+H]+ 452.2809;
found 452.2815.2.2.9. 1-(2-(2-(3-ﬂuorophenyl)-4,5-diphenyl-1H-
imidazol-1-yl)ethyl)piperazine  (5i)
Yield 1.722 g (86%). Yellow gummy solid (after col-
umn chromatography). 1H NMR (CDCl3, 500 MHz) δ
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.04 (s, 4H, (CH2)2NH), 2.22 (t, J  = 7.0 Hz, 2H, CH2),
.65 (t, J  = 4.0 Hz, 4H, (CH2)2N), 4.02 (t, J = 7.0 Hz,
H, CH2), 7.09–7.48 (m, 14H); 13C NMR (CDCl3,
25 MHz) δ  42.07, 45.52, 54.06, 58.31, 115.74, 115.91,
16.28, 116.46, 124.84, 124.86, 126.39, 126.75, 128.05,
28.88, 129.15, 129.92, 130.23, 130.29, 131.03, 131.11,
33.35, 133.42, 134.26, 137.98, 146.54, 146.56; HRMS
ESI): calculated for C27H27FN4 [M+H]+ 427.2293;
ound 427.2298.
.2.10.  1-(2-(2-(3-bromo-4-ﬂuorophenyl)-4,5-
iphenyl-1H-imidazol-1-yl)ethyl)piperazine  (5j)
Yield 2.108 g (89%). white solid, mp 110–112 ◦C.
H NMR (CDCl3, 500 MHz) δ  2.08 (s, 4H, (CH2)2NH),
.14 (d, J  = 6.0 Hz, 2H, CH2), 2.66 (s, 4H, (CH2)2N),
.88 (d, J  = 6.0 Hz, 2H, CH2), 7.00–7.92 (m, 13H); 13C
MR (CDCl3, 125 MHz) δ  42.24, 43.44, 51.16, 57.56,
0.26, 109.24, 109.41, 116.63, 116.80, 126.51, 126.73,
28.08, 128.83, 128.87, 128.99, 129.22, 129.72, 129.78,
29.90, 130.76, 130.82, 134.02, 134.26, 138.06, 145.40,
58.25, 160.24, 170.95,; HRMS (ESI): calculated for
27H26BrFN4 [M+H]+ 505.1398; found 505.1403.
.2.11. 2-bromo-4-(4,5-diphenyl-1-(2-(piperazin-1-
l)ethyl)-1H-imidazol-2-yl)phenol  (5k)
Yield 2.147 g (91%). Yellow solid, mp 160–162 ◦C.
H NMR (CDCl3, 400 MHz) δ  2.10 (s, 4H, (CH2)2NH),
.17 (s, 2H, CH2), 2.71 (s, 4H, (CH2)2N), 3.97 (s,
H, CH2), 6.89–7.77 (m, 13H); 13C NMR (CDCl3,
00 MHz) δ  29.69, 30.94, 43.40, 50.50, 111.23, 127.10,
28.23, 129.29, 130.76, 133.83, 137.50, 147.40; HRMS
ESI): calculated for C27H27BrN4O [M+H]+ 503.1441;
ound 503.1447.
.2.12.  1-(2-(2-(3,4-dichlorophenyl)-4,5-diphenyl-
H-imidazol-1-yl)ethyl)piperazine  (5l)
Yield 1.946 g (87%). Yellow solid, mp 115–117 ◦C.
H NMR (CDCl3, 500 MHz) δ  2.21 (s, 6H, (CH2)2NH)
nd CH2), 2.82 (s, 4H, (CH2)2N), 3.97 (d, J  = 4.5 Hz,
H, CH2), 7.10–7.86 (m, 13H); 13C NMR (CDCl3,
25 MHz) δ 42.31, 42.84, 49.98, 51.79, 57.34, 126.70,
26.87, 127.94, 128.17, 129.14, 129.32, 130.18, 130.63,
30.81, 130.84, 131.01, 132.94, 133.26, 133.81, 138.38,
45.44; HRMS (ESI): calculated for C27H26Cl2N4
M+H]+ 477.1608; found 477.1615.
.2.13.  1-(2-(2-(2,3-dichlorophenyl)-4,5-diphenyl-
H-imidazol-1-yl)ethyl)piperazine  (5m)Yield 1.852 g (90%). Yellow gummy solid (after col-
mn chromatography). 1H NMR (CDCl3, 400 MHz) δ
.21–2.27 (m, 6H, (CH2)2NH) and CH2), 2.82 (s, 4H,
CH2)2N), 4.0 (t, J  = 6.8 Hz, 2H, CH2), 7.04–7.87 (m,ersity for Science 9 (2015) 498–507 501
13H); 13C NMR (CDCl3, 100 MHz) δ  42.33, 43.13,
50.53, 50.93, 51.57, 57.48, 126.73, 126.87, 127.17,
128.19, 128.79, 129.15, 129.33, 130.16, 130.72, 130.81,
130.89, 131.03, 132.99, 133.32, 133.84, 138.45, 145.48;
HRMS (ESI): calculated for C27H26Cl2N4 [M+H]+
477.1608; found 477.1615.
2.2.14.  1-(2-(2-(3,5-dimethoxyphenyl)-4,5-
diphenyl-1H-imidazol-1-yl)ethyl)piperazine  (5n)
Yield 1.826 g (83%). Yellow gummy solid (after col-
umn chromatography). 1H NMR (CDCl3, 400 MHz)
δ 2.09 (s, 4H, (CH2)2NH), 2.25 (t, J  = 7.6 Hz, 2H,
CH2), 2.72 (s, 4H, (CH2)2N), 3.95 (d, J  = 8.4 Hz, 6H,
(OCH3)2), 4.02 (t, J = 7.6 Hz, 2H, CH2), 6.93–7.52 (m,
13H); 13C NMR (CDCl3, 100 MHz) δ  44.76, 52.96,
55.99, 56.09, 110.98, 112.72, 121.62, 126.33, 126.83,
128.06, 128.77, 129.14, 129.34, 131.05, 149.08; HRMS
(ESI): calculated for C29H32N4O2 [M+H]+ 469.2599;
found 469.2603.
2.2.15.  1-(2-(4,5-diphenyl-2-(3,4,5-
trimethoxyphenyl)-1H-imidazol-1-yl)ethyl)
piperazine  (5o)
Yield 2.107 g (90%). Yellow solid, mp 62–64 ◦C. 1H
NMR (CDCl3, 500 MHz) δ 2.11 (s, 4H, (CH2)2NH),
2.21 (d, J  = 5.0 Hz 2H, CH2), 2.72 (s, 4H, (CH2)2N),
3.81–3.86 (m, 9H, (OCH3)3), 3.98 (d, J = 5.0 Hz,
2H, CH2), 6.82–7.46 (m, 12H); 13C NMR (CDCl3,
125 MHz) δ  42.02, 43.06, 43.10, 50.40, 50.47, 56.33,
57.55, 60.34, 60.93, 106.59, 126.45, 126.47, 126.82,
128.06, 128.91, 129.20, 129.42, 130.88, 131.01, 134.08,
137.61, 138.87, 147.75, 153.37; HRMS (ESI): calculated
for C30H34N4O3 [M+H]+ 499.2704; found 499.2709.
3.  Results  and  discussion
We began our investigation with the condensa-
tion reaction of benzil (1 mmol), aminoethylpiperazine
(1 mmol), benzaldehyde (1 mmol) and ammonium
acetate (2 mmol) in ethanol at 80 ◦C in the absence of
catalyst for 10 h, and no product formation was observed
(Table 1, entry 1). Next, we performed the reaction in
the presence of catalysts, such as p-toluenesulphonic
acid (PTSA), ceric ammonium nitrate (CAN), acetic acid
(AcOH) and l-proline.
The multicomponent condensation reaction to
synthesize 1,2,4,5-tetrasubstituted imidazoles was per-
◦formed at 80 C using 5 mol% and 10 mol% PTSA
in ethanol, and we obtained only 24% and 20%
yields, respectively, in 10 h (Table 1, entries 2 and 3,
respectively). Further investigation was performed using
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Table 1
Optimization of the reaction condition for compound 5a.a
Entry Catalyst Catalyst loading (mol%) Temperature (◦C) Time (h) Yieldb (%)
1 No catalyst – 80 10 –
2 PTSA 5 80 10 24
3 PTSA 10 80 10 20
4 CAN 5 80 10 47
5 CAN 10 80 10 43
6 AcOH 5 80 10 51
7 AcOH 10 80 10 50
8 l-proline 5 80 10 63
9 l-proline 10 80 10 60
10 SO42−/Y2O3 (5 wt%) – 80 10 93
a Reaction scale: 1 (1 mmol), 2 (1 mmol), 3 (1 mmol), 4 (2 mmol).
b Isolated yield.
5 mol% and 10 mol % CAN as a catalyst for the conden-
sation reaction over 10 h, yielding only 47% and 43% of
products, respectively (Table 1, entries 4 and 5, respec-
tively).
The same condensation reaction was performed at
80 ◦C using 5 mol% and 10 mol% AcOH, yielded the
corresponding substituted imidazole in 51% and 50%
yields, respectively, after 10 h (Table 1, entries 6 and
7, respectively). The same condensation reaction was
attempted using 5 mol% and 10 mol% of l-proline as
a catalyst for 10 h, yielding only 63% and 60%, respec-
tively (Table 1, entries 8 and 9, respectively). From these
results, we concluded that the mentioned catalysts are
moderately efficient for this condensation reaction.
To enhance the yield of the MCR, sulphated yttria
(SO42−/Y2O3) was used as a catalyst, and the results
revealed that the reaction was complete within 10 h
and yielded the corresponding imidazole in 93% yield
(Table 1, entry 10). This result proved that when sul-
phated yttria is used as the catalyst, the product yield
was nearly doubled compared with the previously used
catalysts.
The scope and efficiency of the method was
explored under optimized conditions. For this purpose,various aromatic aldehydes were condensed with ben-
zil, aminoethylpiperazine and ammonium acetate under
a conventional heating method, and the results are
given in Table 3. An increased yield of products was
observed with aromatic aldehydes containing electron-
releasing groups compared with electron-withdrawing
substituents in the aromatic ring.
Among the various catalysts used for the synthesis
of 1,2,4,5-tetrasubstituted imidazoles, sulphated yttria
showed better catalytic efficiency (Table 1). One of the
major advantages of this protocol is the easy isolation
and purification of the products achieved by column
chromatography.
The structure and morphology of the catalyst are
important parameters because they control the catalytic
activity. The surface morphology of sulphated yttria was
analyzed by SEM techniques. The SEM images at two
different levels of magnification are shown in Fig. 1a
and b. Generally, the SEM images showed agglomerated
“flaky or platy” morphology (Fig. 1a and b). Exces-
sive particle growth up to the micrometre size was also
observed in both of the magnifications.
Transmission electron microscopic (TEM) analysis
also reveals the catalytic activity of the prepared material.
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ions in certain locations are shown in Fig. 2a–d. Due to
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izes of the particles are over the range of 3–100 nm.
X-ray diffractograms of the commercially avail-
ble Y2O3 and prepared SO42−/Y2O3 are shown in
ig. 3. The 2θ  values of the prepared SO42−/Y2O3 at
0.35◦, 29.02◦, 33.62◦, 35.76◦, 39.83◦, 43.34◦, 48.38◦,
3.10◦, 57.49◦, 60.38◦, 71.09◦ and 78.57◦ correspond
o the (2 2 1), (2 2 2), (4 0 0), (4 1 1), (3 3 2), (1 3 4),
4 4 0), (6 1 1), (6 2 2), (4 4 4), (8 0 0) and (6 2 2) diffrac-
ion planes of cubic Y2O3 [JCPDS No. 65-3178] [36]
Fig. 3a)
.
All of the diffraction peaks of SO42−/Y2O3
erfectly matched the cubic phase of Y2O3 (Fig. 3b).
herefore, the crystallographic phase of the prepared SO42−/Y2O3.
SO42−/Y2O3 was confirmed as the cubic Y2O3 form
in the prepared catalyst. The addition of sulphuric acid
during the formation of SO42−/Y2O3 does not change
the cubic phase of Y2O3. The diffraction peaks of
SO42−/Y2O3 are sharp and strong, which indicates the
highly crystalline nature of SO42−/Y2O3. The Scher-
rer formula employed for the precise calculation of the
crystallite sizes of SO42−/Y2O3 is as follows:
Φ  = Kλ
β  cos θ
where Φ is the crystallite size, λ  is the wavelength of the
X-ray used, K  is the shape factor, β  is the full line width
at the half-maximum height of the main intensity peak,
and θ  is the Bragg angle. From this equation, the average
crystallite size of SO42−/Y2O3 was found to be 4.8 nm.
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Fig. 2. TEM images of SO42−/Y2O3 (a) 100 nm, (b) 100 nm, (c) 50 nm and (d) 50 nm.
Fig. 3. PXRD images of SO42−/Y2O3.While evaluating the influence of different solvent
systems for the SO42−/Y2O3-catalyzed synthesis of
1,2,4,5-tetrasubstituted imidazoles, the role of solvents,
such as water, methanol, ethanol, iso-propanol, tert-
butanol, acetonitrile, dichloromethane and chloroform,
was examined. Among these solvents, ethanol was found
to be the best medium to obtain optimum yields (Table 2).
All of the synthesized products were characterized by IR,
HR-MS, 1H and 13C NMR spectra. The numbering of
compound 5a  is shown in Fig. 4.
In the 1H NMR spectrum of compound 5a  (Fig. S5), in
addition to the aromatic proton signal at 7.12–7.72 ppm
with 15 protons, the NH proton signal of the piperazine
ring appears as a broad singlet at 2.44 ppm. In the higher
frequency region, one triplet appeared at 4.03 ppm that
is assigned to the methylene protons of the C6 car-
bon. Methylene protons of the C7 carbon appeared at
2.23 ppm as a triplet. There are two signals at 2.64 and
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Table 2
Synthesis of compound 5a using SO42−/Y2O3 in different solvents.
Entry Solvent Temperature (◦C) Time (h) Yieldb (%)
1 Solvent free 80 10 40
2 Water 80 10 No reaction
3 Methanol 80 10 89
4 Chloroform 80 10 58
5 Acetonitrile 80 10 84
6 Dichloromethane 80 10 36
7 tert-butanol 80 10 54
8 iso-propanol 80 10 67
9 Ethanol 80 10 93
b Yields refer to isolated products.
2
d
a
N
2
p
S
o
T
1
4
C
i
N
N
t
c
a
s
a
a
Table 3
SO42−/Y2O3 catalyzed synthesis of 1,2,4,5-tetrasubstituted
imidazoles.a
Entry R1 R2 R3 R4 Product Time Yieldb
a H H H H 5a 10 93
b H H CH3 H 5b 10 93
c H H Br H 5c 10 92
d H H Cl H 5d 10 91
e H H F H 5e 10 91
f H H NO2 H 5f 10 87
g H H OCH3 H 5g 10 92
h H H N-(CH3)2 H 5h 10 91
I H F H H 5i 10 86
j H Br F H 5j 10 89
k H Br OH H 5k 10 91
l H Cl Cl H 5l 10 87
m Cl Cl H H 5m 10 90
n H OCH3 H OCH3 5n 10 83
o H OCH3 OCH3 OCH3 5o 10 90
a Benzil:benzaldehyde:aminoethylpiperazine:NH4OAc
(1 mmol:1 mmol:1 mmol:2 mmol).
b Isolated yield.
Table 4
Recyclability of SO42−/Y2O3 catalyst.
Cycles Yield (%) Catalyst recovered (%)
Native 93 96
1 92 94
2 90 92
3 87 91
Networking Resource Centre, University of Hyderabad,
India for providing characterization facilities and Dr.Fig. 4. Numbering of compound 5a.
.02 ppm with eight protons. Of these two signals, one
eshielded signal appearing as a triplet at 2.64 ppm is
ssigned to two sets of methylene protons attached to
8, whereas the shielded signal appearing as a singlet at
.02 ppm is due to the remaining two sets of methylene
rotons connected to N11.
In the 13C NMR spectrum of compound 5a  (Fig.
5), the signal appearing at 147.96 ppm is unambigu-
usly assigned to the imino carbon of the imidazole ring.
he aromatic carbon signals appeared in the region of
37.75–126.31 ppm. The signals observed at 58.36 and
1.88 ppm are assigned to methylene carbons C7 and
6, respectively, and the signal observed at 54.07 ppm
s due to methylene carbons C10 and C12 connected to
11. The methylene carbons C9 and C13 connected to
8 appeared at 45.62 ppm.
To determine the reusability of the catalyst, the reac-
ion mass was cooled to room temperature, and the
atalyst was filtered and washed with ice-cold methanol
nd then dried. The recovered catalyst was used in four
uccessive cycles, furnishing the corresponding imid-
zole with 92%, 90%, 87% and 78% isolated yields
s shown in Table 4. It was observed that the yields4 78 90
of tetrasubstituted imidazoles diminished slightly after
every cycle.
4.  Conclusions
We developed a simple and efficient one-pot method-
ology for the synthesis of tetrasubstituted imidazoles
catalyzed by SO42−/Y2O3. The advantages of this
method are the high conversion, simple operation, cost
efficiency, easy work up and recyclability of the catalyst.
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